Pharmacology in Dermatology Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Prescribing Difficulties in Dermatology

A

Difficulty in dermatology with rarity of some skin conditions and lack of evidence behind treatments.

3-6% of hospital admissions are due to adverse drug reactions
Half are preventable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Licensed medication

A
Approved for use in UK either by
MHRA – Medicines and Healthcare Products Regulatory Agency
EMA – European Medicines Agency
High standards of safety and quality
Trial evidence to show positive effect 

** SMC submission
Scottish Medicines Consortium **

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Medicine without licence

A

Unlicensed
Not approved for use in the UK
‘Off label’
A licensed medication that is being used for an unlicensed indication
‘Specials’
unlicensed dermatological preparations
Long history of use, no strong evidence base but clinically effective.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Causes of prescription errors

A

Lack of knowledge
About the patient, the medication, allergies
Mistake writing/generating the prescription
Poor communication
No local or national guidelines

Pharmacy/medicine info service

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Patient adherence

A

Between one third to a half of all medicines prescribed for long term conditions are not taken as recommended

Essential to take a non-judgmental approach
Not the patient’s problem
Not about taking more medication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Factors associated with poor adherence

A
Psychiatric co-morbidities
Slower acting agents
Multiple applications per day
Lack of patient education
Cosmetic acceptability of treatments
Unintentional non-adherence 

** The NHS spends £100 million annually on unused medicine **

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pharmacology

A

The branch of medicine concerned with the uses, effects, and modes of action of drugs.

Pharmacokinetics
The effect of the body on the drug
Pharmacodynamics
The effect of the drug on the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pharmacokinetics

A

Need to think about route of administration
topically where possible
If oral, optimal absorption important

Distribution – where the drug goes
Metabolism – especially in liver disease
Excretion – especially in renal disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pharmacodynamics

A
Individual variation in response
Think about
Age of patient
Pregnancy risk
Drug interactions
Pharmacogenetics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Topical therapy

A

Medication applied to the skin
Vehicle + active drug

Vehicle: pharmacologically inert, physically and chemically stable substance that carries the active drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Factors that affect topical absorption

A
Concentration
Base/vehicle
Chemical properties of the drug
Thickness and hydration of stratum corneum
Temperature
Skin site
Occlusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Vehicle 11

A
Solution 				
Paste
Cream 				
Spray powder
Lotion				
Shampoo
Gel					
Ointment
Foam				
Paint
Tape
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Drugs used topically

A

Examples include:

Corticosteroid			Chemotherapy
Antibiotic			Parasiticidals
Antiviral				Coal Tar
Dithranol			
Anti-inflammatory
Vitamin analogues		Salicylic acid

The next generation – topical immunomodulators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Topical Steroids

A

Anti- inflammatory and immunosuppressive properties
Regulate pro inflammatory cytokines
Suppress fibroblast, endothelial, and leukocyte function
Vasoconstriction
Inhibit vascular permeability

Range of potencies

Used appropriately – very safe

Prescribe enough!
See BNF guide for adults
Can use finger-tip units.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Finger tip unit

A

About 0.5 g

Should treat area double the size of one hand

Useful in young children

Charts available for age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Side effects of topical steroids

A
Thinning /atrophy
Striae
Bruising
Hirsutism
Telangiectasia
Acne/rosacea/perioral dermatitis
Glaucoma
Systemic absorption
Cataracts
17
Q

Systemic Treatments in Dermatology

A

Retinoids
Traditional immunosuppressants
Biologics (also immunosuppressive)

18
Q

Retinoids

A
Vitamin A analogues
Normalise keratinocyte function
Anti inflammatory and anti cancer effects
Four different molecules used orally in dermatology
Effective in:
Acne - isotretinoin
Psoriasis - acitretin
Cutaneous T cell lymphoma - bexarotene
 Hand eczema - alitretinoin
19
Q

Retinoids complications

A

Teratogenic
Careful patient selection

Side effects include
Cheilitis(dry lips) and xerosis (dry skin)
↑transaminases, ↑triglycerides
Rarely psychiatric, eye, bone side effects

20
Q

Immunosuppressants

A

Treatment of inflammatory skin disorders

Oral steroids
Azathioprine
Ciclosporin
Methotrexate
Mycophenolate mofetil
21
Q

Immunosuppressants complications

A

Risk of malignancy and serious infection

Need regular blood test monitoring, in particular
FBC (esp in methotrexate and azathioprine)
Renal function (esp ciclosporin)
Liver function (esp methotrexate)

22
Q

Biologics in Dermatology

A

The next generation in treatment of inflammatory conditions
Genetically engineered proteins derived from human genes
designed to inhibit specific components of the immune system
Very effective, but expensive

23
Q

Suffix ‘-cept’

A

Suffix ‘-cept’ indicates that it is a it is a Receptor fusion
Etanercept -genetically engineered fusion protein

24
Q

Suffix “-mab”

A

Suffix “-mab” is used to denote monoclonal antibodies

25
Q

A series of infixes which immediately precede –mab:

A

A series of infixes which immediately precede –mab:
zu humanised
ix chimeric
u fully human
li-/-l- immunomodulator
E.g.adalimumab = immunomodulator fully human monoclonal antibodies
Infliximab = immunomodulator chimeric monoclonal antibodies

26
Q

Current licensed biologics for dermatology conditions

A
Psoriasis – nine
Hidradenitis suppurativa – one
Chronic spontaneous urticaria – one
Atopic eczema – one
Pemphigus – one
27
Q

Biologic tx complications

A
Risk of infection
TB reactivation
Serious infection
Avoid live vaccines 
Risk of malignancy
TNF inhibitors – risk of demyelination
28
Q

Melanoma tx

A
A revolution in treatment options for advanced melanoma
Targeted treatment for stage 4 disease
Adjuvant use in stage 3 disease
Targeted treatment
If BRAF 600 mutation
Vemurafenib
Dabrafenib
Immunotherapies
Ipilumumab
Pembrolizumab